Morgan Stanley Issues Pessimistic Forecast for Hologic (NASDAQ:HOLX) Stock Price
Hologic (NASDAQ:HOLX – Get Free Report) had its price objective decreased by investment analysts at Morgan Stanley from $77.00 to $65.00 in a note issued to investors on Monday, Marketbeat reports. The firm currently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s price objective would suggest a potential upside of […]
Hologic (NASDAQ:HOLX – Get Free Report) had its price objective decreased by investment analysts at Morgan Stanley from $77.00 to $65.00 in a note issued to investors on Monday, Marketbeat reports. The firm currently has an “equal weight” rating on the medical equipment provider’s stock. Morgan Stanley’s price objective would suggest a potential upside of […]
